I/VC  Pittsburgh Life Sciences Greenhouse


     Office Locations:

2425 Sidney Street
Pittsburgh, PA 15203
Phone: 412-201-7370
Fax: 412-770-1276



  • Early
  • Growth
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    The Pittsburgh Life Sciences Greenhouse (PLSG) is a public/private partnership, founded in 2001 by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System and the Commonwealth of Pennsylvania. The PLSG provides capital investments, customized company formation, and business growth services to life sciences enterprises, supporting biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG has two incubator facilities equaling 22,000 square feet of available space for growing companies. The main Incubator is located with PLSG's administrative offices. It is a 13,000 square-foot facility consisting of 40 percent modern wet lab space and 60 percent office space. The second facility, PLSG West, is 9,000 square-feet of mostly laboratory space. The PLSG Investment Funds help seed and early-stage life sciences companies rapidly achieve company formation and technology commercialization milestones. Since forming in 2002, the organization has committed over $19 million into its investment portfolio of 76 life sciences companies, which have attracted over $840 million in additional capital.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Don Taylor MBA, PhD EIR
    Hank Safferstein PhD, JD EIR
    James Jordan Vice President and Chief Investment Officer
    John W. Manzetti President and Chief Executive Officer
    Philip G. Petraglia CPA Vice President


    Portfolio companies include:

        web link

        web link

      Applied Isotope Technologies
        web link

      ATRP Solutions
        web link

        web link

        web link

      Caliber Infosolutions
        web link

        web link

        web link

        web link

        web link

        web link

      Chronic Health Metrics
        web link

      Cognition Therapeutics
        web link

        web link

        web link

        web link

      Falcon Genomics
        web link

      Health Monitoring Systems
        web link

        web link

      ICx Agentase
        web link

        web link

        web link

      KeyBay Pharma
        web link

      Knopp Biosciences
        web link

        web link

      Lipella Pharmaceuticals
        web link

        web link

      Midas Bio
        web link

      Parent Plus
        web link

        web link

      Quantum Ops
        web link

      RedPath Integrated Pathology
        web link

        web link

      STARR Life Sciences
        web link

        web link

      Washburn Therapeutics
        web link

      Wright Therapy Products
        web link


    Recent News: